loading
Schlusskurs vom Vortag:
$17.01
Offen:
$17.25
24-Stunden-Volumen:
1.01M
Relative Volume:
0.33
Marktkapitalisierung:
$12.77B
Einnahmen:
$220.00K
Nettoeinkommen (Verlust:
$-746.08M
KGV:
-17.02
EPS:
-1.0074
Netto-Cashflow:
$-211.81M
1W Leistung:
-4.96%
1M Leistung:
+1.72%
6M Leistung:
-15.19%
1J Leistung:
+0.70%
1-Tages-Spanne:
Value
$16.98
$17.38
1-Wochen-Bereich:
Value
$16.87
$18.02
52-Wochen-Spanne:
Value
$15.55
$36.91

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
Firmenname
Summit Therapeutics Inc
Name
Telefon
305-203-2034
Name
Adresse
601 BRICKELL KEY DRIVE, MIAMI
Name
Mitarbeiter
159
Name
Twitter
@summitplc
Name
Nächster Verdiensttermin
2025-10-20
Name
Neueste SEC-Einreichungen
Name
SMMT's Discussions on Twitter

Vergleichen Sie SMMT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SMMT
Summit Therapeutics Inc
17.16 12.66B 220.00K -746.08M -211.81M -1.0074
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.46 114.05B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
748.47 78.80B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
850.32 53.08B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
395.76 51.80B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
164.56 42.33B 447.02M -1.18B -906.14M -6.1812

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-11-18 Eingeleitet Wolfe Research Peer Perform
2025-09-17 Eingeleitet Barclays Underweight
2025-09-04 Eingeleitet Guggenheim Buy
2025-08-19 Eingeleitet Piper Sandler Neutral
2025-07-01 Eingeleitet UBS Buy
2025-06-11 Eingeleitet Leerink Partners Underperform
2025-03-26 Hochstufung Citigroup Neutral → Buy
2025-03-21 Eingeleitet Cantor Fitzgerald Overweight
2025-03-12 Eingeleitet Evercore ISI Outperform
2025-02-28 Eingeleitet Goldman Buy
2025-01-08 Eingeleitet Truist Buy
2024-12-11 Eingeleitet Wells Fargo Overweight
2024-12-06 Eingeleitet Jefferies Buy
2024-11-04 Eingeleitet JMP Securities Mkt Outperform
2024-09-27 Herabstufung Citigroup Buy → Neutral
2024-08-12 Eingeleitet H.C. Wainwright Buy
2024-05-07 Eingeleitet Citigroup Buy
2024-03-26 Eingeleitet Stifel Buy
2018-06-28 Herabstufung Janney Buy → Neutral
2018-05-02 Eingeleitet Janney Buy
2018-04-12 Bestätigt Needham Buy
2018-02-13 Eingeleitet BTIG Research Buy
2018-01-04 Eingeleitet SunTrust Buy
2017-12-01 Fortgesetzt H.C. Wainwright Buy
2016-11-16 Bestätigt RBC Capital Mkts Outperform
2016-10-05 Bestätigt Needham Buy
2016-09-16 Eingeleitet H.C. Wainwright Buy
2015-03-30 Eingeleitet Needham Buy
2015-03-30 Eingeleitet Oppenheimer Outperform
Alle ansehen

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
12:08 PM

Gains Recap: Will Summit Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Улправда

12:08 PM
pulisher
03:41 AM

Will Summit Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Weekly High Momentum Picks - Улправда

03:41 AM
pulisher
Dec 17, 2025

Barclays Upgrades Summit Therapeutics (SMMT) - Nasdaq

Dec 17, 2025
pulisher
Dec 17, 2025

Barclays Upgrades SMMT, Raises Price Target to $18 | SMMT Stock News - GuruFocus

Dec 17, 2025
pulisher
Dec 17, 2025

Summit Therapeutics (NASDAQ:SMMT) Upgraded by Barclays to Equal Weight Rating - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

Summit Therapeutics stock rating upgraded by Barclays on BLA timeline - Investing.com UK

Dec 17, 2025
pulisher
Dec 17, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat

Dec 17, 2025
pulisher
Dec 13, 2025

Trading Systems Reacting to (SMMT) Volatility - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 11, 2025

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

Citi asserts buy rating on Summit Therapeutics Inc. (SMMT) on pipeline development - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

Has Summit Therapeutics Rally Left Enough Upside After 448.6% Surge and DCF Upswing? - Yahoo Finance

Dec 11, 2025
pulisher
Dec 09, 2025

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

U.S. Markets Ended Tuesday Mixed As Galaxy Digital Led, Summit Therapeutics Lagged - Barron's

Dec 09, 2025
pulisher
Dec 09, 2025

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility - ts2.tech

Dec 09, 2025
pulisher
Dec 09, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Down 4.4%Here's Why - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

New York State Common Retirement Fund Buys 227,513 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 07, 2025
pulisher
Dec 06, 2025

Schroder Investment Management Group Sells 89,090 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

State Board of Administration of Florida Retirement System Boosts Stake in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - Finviz

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - The Motley Fool

Dec 05, 2025
pulisher
Dec 05, 2025

Why analysts upgrade Summit Therapeutics Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Inc. (SMMT) Options Chain - Yahoo! Finance Canada

Dec 05, 2025
pulisher
Dec 04, 2025

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - AOL.com

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading 9.2% HigherShould You Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Can Summit Therapeutics Inc. stock maintain operating marginsWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics Earnings Notes - Trefis

Dec 04, 2025
pulisher
Dec 03, 2025

Don't Buy Summit Therapeutics Until This Big Thing Happen - Nasdaq

Dec 03, 2025
pulisher
Dec 02, 2025

Widening Q3 Losses and Insider Buying Might Change The Case For Investing In Summit Therapeutics (SMMT) - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

SMMT: Four positive phase 3 trials and accelerated timelines position the pipeline for NSCLC market leadership - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

2 Monster Stocks in the Making to Buy and Hold - The Globe and Mail

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics: InvestingPro’s Fair Value model predicted 37% downside By Investing.com - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 01, 2025

Summit Therapeutics (SMMT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 29, 2025

33,096 Shares in Summit Therapeutics PLC $SMMT Acquired by Inceptionr LLC - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Rhenman & Partners Asset Management AB Makes New Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

WE Convention 2025: Dr. Maky Zanganeh, Co-CEO and President, Summit Therapeutics - Entrepreneur

Nov 26, 2025
pulisher
Nov 26, 2025

January 2026 Options Now Available For Summit Therapeutics (SMMT) - Nasdaq

Nov 26, 2025
pulisher
Nov 25, 2025

Summit Therapeutics Inc. (SMMT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 25, 2025
pulisher
Nov 25, 2025

Cynosure Group LLC Buys Shares of 18,609 Summit Therapeutics PLC $SMMT - MarketBeat

Nov 25, 2025
pulisher
Nov 24, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 24, 2025
pulisher
Nov 23, 2025

40,169 Shares in Summit Therapeutics PLC $SMMT Acquired by Neo Ivy Capital Management - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

(SMMT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 21, 2025
pulisher
Nov 20, 2025

Summit C-Suite Risks Success, Akeso Wins Either Way (OTCMKTS:AKESF) - Seeking Alpha

Nov 20, 2025
pulisher
Nov 20, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

ProShare Advisors LLC Sells 25,455 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Nov 20, 2025
pulisher
Nov 19, 2025

Is Summit Therapeutics Inc. building a consolidation baseMarket Rally & Weekly Top Stock Performers List - newser.com

Nov 19, 2025

Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.35
price up icon 0.21%
$97.55
price down icon 0.15%
$31.54
price down icon 0.52%
$91.78
price down icon 0.00%
biotechnology ONC
$308.29
price up icon 0.58%
$163.96
price down icon 17.26%
Kapitalisierung:     |  Volumen (24h):